These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11834431)

  • 1. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.
    Arlt W; Fremerey C; Callies F; Reincke M; Schneider P; Timmermann W; Allolio B
    Eur J Endocrinol; 2002 Feb; 146(2):215-22. PubMed ID: 11834431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
    Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis.
    Mortensen L; Hyldstrup L; Charles P
    Eur J Endocrinol; 1997 Jan; 136(1):52-60. PubMed ID: 9037127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism.
    Parfitt AM
    J Clin Invest; 1972 Jul; 51(7):1879-88. PubMed ID: 4338123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study.
    Mazoni L; Matrone A; Apicella M; Saponaro F; Borsari S; Pardi E; Cosci B; Biagioni I; Rossi P; Pacciardi F; Scionti A; Elisei R; Marcocci C; Cetani F
    J Endocrinol Invest; 2022 Mar; 45(3):573-582. PubMed ID: 34637114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review.
    Büttner M; Singer S; Taylor K
    Endocrine; 2024 Jul; 85(1):80-90. PubMed ID: 38578400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.
    Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M
    Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
    Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update on recent progress in vitamin D research. Vitamin D treatment for hypoparathyroidism.].
    Minagawa M
    Clin Calcium; 2017; 27(11):1623-1628. PubMed ID: 29074836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative hypoparathyroidism: medical and surgical therapeutic options.
    Walker Harris V; Jan De Beur S
    Thyroid; 2009 Sep; 19(9):967-73. PubMed ID: 19731978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypovitaminosis D and 'functional hypoparathyroidism'-the NoNoF (Nottingham Neck of Femur) study.
    Sahota O; Gaynor K; Harwood RH; Hosking DJ
    Age Ageing; 2001 Nov; 30(6):467-72. PubMed ID: 11742774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.
    Neer RM; Holick MF; DeLuca HF; Potts JT
    Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
    Rejnmark L; Gosmanova EO; Khan AA; Makita N; Imanishi Y; Takeuchi Y; Sprague S; Shoback DM; Kohlmeier L; Rubin MR; Palermo A; Schwarz P; Gagnon C; Tsourdi E; Zhao C; Makara MA; Ominsky MS; Lai B; Ukena J; Sibley CT; Shu AD
    Adv Ther; 2024 Jun; 41(6):2500-2518. PubMed ID: 38691316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
    Kruse K; Kracht U; Wohlfart K; Kruse U
    Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D treatment of hypoparathyroid patients.
    Rizzoli R; Bonjour JP
    Eur J Endocrinol; 1997 Jan; 136(1):25-7. PubMed ID: 9037118
    [No Abstract]   [Full Text] [Related]  

  • 18. The HPQ-Development and First Administration of a Questionnaire for Hypoparathyroid Patients.
    Wilde D; Wilken L; Stamm B; Blaschke M; Heppner C; Chavanon ML; Leha A; Herrmann-Lingen C; Siggelkow H
    JBMR Plus; 2020 Jan; 4(1):e10245. PubMed ID: 31956849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of postoperative hypoparathyroidism on bone density.
    Hurxthal LM; Dotter WE; Vose GP; Sprinkle EE
    Tex Rep Biol Med; 1976; 34(2-4):257-65. PubMed ID: 1030538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.